Hbk Investments L P Verona Pharma PLC Transaction History
Hbk Investments L P
- $7.23 Billion
- Q3 2025
A detailed history of Hbk Investments L P transactions in Verona Pharma PLC stock. As of the latest transaction made, Hbk Investments L P holds 4,263,576 shares of VRNA stock, worth $456 Million. This represents 6.29% of its overall portfolio holdings.
Number of Shares
4,263,576Holding current value
$456 Million% of portfolio
6.29%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
72.8MCall Options Held
652KPut Options Held
637K-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$441 Million16.48% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
-
Glazer Capital, LLC New York, NY3.21MShares$343 Million11.48% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...